Caturano A, Erul E, Nilo R, Nilo D, Russo V, Rinaldi L
Mol Cell Biochem. 2025; .
PMID: 40089612
DOI: 10.1007/s11010-025-05245-8.
Promsan S, Pengrattanachot N, Phengpol N, Sutthasupha P, Thongnak L, Jaikumkao K
Int J Mol Sci. 2025; 26(5).
PMID: 40076566
PMC: 11900133.
DOI: 10.3390/ijms26051940.
Ghimire N, Welch M, Secunda C, Fink A, Lawan A
Cells. 2025; 14(4).
PMID: 39996734
PMC: 11853640.
DOI: 10.3390/cells14040261.
Singh S, Singh T
J Tradit Complement Med. 2025; 14(6):581-597.
PMID: 39850604
PMC: 11752125.
DOI: 10.1016/j.jtcme.2024.04.009.
Amer J, Amleh A, Salhab A, Kolodny Y, Yochelis S, Saffouri B
Front Nutr. 2025; 11:1469952.
PMID: 39742098
PMC: 11687001.
DOI: 10.3389/fnut.2024.1469952.
Bioinformatics Analysis and Experimental Findings Reveal the Therapeutic Actions and Targets of Against Type 2 Diabetes Mellitus.
Zhang X, Sun Z, Sun W, Li Y, Gao F, Teng F
J Diabetes Res. 2024; 2024:5521114.
PMID: 39534794
PMC: 11557179.
DOI: 10.1155/2024/5521114.
Systemic Inflammation Across Metabolic Obesity Phenotypes: A Cross-Sectional Study of Korean Adults Using High-Sensitivity C-Reactive Protein as a Biomarker.
Baek S, Yoon J
Int J Mol Sci. 2024; 25(21).
PMID: 39519093
PMC: 11547168.
DOI: 10.3390/ijms252111540.
Effect of green coffee on miR-133a, miR-155 and inflammatory biomarkers in obese individuals.
Khedr N, Zahran E, Ebeid A, Melek S, Werida R
Diabetol Metab Syndr. 2024; 16(1):256.
PMID: 39468643
PMC: 11520395.
DOI: 10.1186/s13098-024-01478-7.
Pharmacology of P2X Receptors and Their Possible Therapeutic Potential in Obesity and Diabetes.
Cabral-Garcia G, Cruz-Munoz J, Valdez-Morales E, Barajas-Espinosa A, Linan-Rico A, Guerrero-Alba R
Pharmaceuticals (Basel). 2024; 17(10).
PMID: 39458933
PMC: 11509955.
DOI: 10.3390/ph17101291.
Exploring the Antidiabetic Potential of Using Network Pharmacology, Molecular Docking and ADME/Drug-Likeness Predictions.
Ononamadu C, Seidel V
Plants (Basel). 2024; 13(20).
PMID: 39458839
PMC: 11510882.
DOI: 10.3390/plants13202892.
A Study of 's Promoter Region and Its Regulators in Chickens.
Kong R, Shi J, Xie K, Wu H, Wang X, Zhang Y
Genes (Basel). 2024; 15(10).
PMID: 39457475
PMC: 11508107.
DOI: 10.3390/genes15101351.
Unveiling the Role of Schwann Cell Plasticity in the Pathogenesis of Diabetic Peripheral Neuropathy.
Abd Razak N, Idris J, Hassan N, Zaini F, Muhamad N, Daud M
Int J Mol Sci. 2024; 25(19).
PMID: 39409114
PMC: 11476695.
DOI: 10.3390/ijms251910785.
Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy.
Lu X, Xie Q, Pan X, Zhang R, Zhang X, Peng G
Signal Transduct Target Ther. 2024; 9(1):262.
PMID: 39353925
PMC: 11445387.
DOI: 10.1038/s41392-024-01951-9.
Impact of monocarbonyl analogs of curcumin (MACs) C66 and B2BrBC on the expression of diabetes-associated genes in streptozotocin-treated rat pancreatic RIN-m cells-Quantitative RT-PCR array data.
Stojchevski R, Velichkovikj S, Bogdanov J, Hadzi-Petrushev N, Mladenov M, Poretsky L
Data Brief. 2024; 57:110952.
PMID: 39351132
PMC: 11440284.
DOI: 10.1016/j.dib.2024.110952.
Impact of Sex on the Therapeutic Efficacy of Rosiglitazone in Modulating White Adipose Tissue Function and Insulin Sensitivity.
Bauza-Thorbrugge M, Amengual-Cladera E, Galmes-Pascual B, Moran-Costoya A, Gianotti M, Valle A
Nutrients. 2024; 16(18).
PMID: 39339665
PMC: 11434741.
DOI: 10.3390/nu16183063.
Molecular Aspects in the Development of Type 2 Diabetes and Possible Preventive and Complementary Therapies.
Simon-Szabo L, Lizak B, Sturm G, Somogyi A, Takacs I, Nemeth Z
Int J Mol Sci. 2024; 25(16).
PMID: 39201799
PMC: 11354764.
DOI: 10.3390/ijms25169113.
JNK2-MMP-9 axis facilitates the progression of intracranial aneurysms.
Ishibashi R, Itani M, Kawashima A, Arakawa Y, Aoki T
Sci Rep. 2024; 14(1):19458.
PMID: 39169203
PMC: 11339388.
DOI: 10.1038/s41598-024-70493-5.
Physiological and metabolic functions of the β-adrenergic receptor and an approach to therapeutic achievements.
Samanta S, Bagchi D, Bagchi M
J Physiol Biochem. 2024; 80(4):757-774.
PMID: 39145850
DOI: 10.1007/s13105-024-01040-z.
The Kidney in Obesity: Current Evidence, Perspectives and Controversies.
Kounatidis D, Vallianou N, Stratigou T, Voukali M, Karampela I, Dalamaga M
Curr Obes Rep. 2024; 13(4):680-702.
PMID: 39141201
DOI: 10.1007/s13679-024-00583-y.
Cysteine-rich 61 inhibition attenuates hepatic insulin resistance and improves lipid metabolism in high-fat diet fed mice and HepG2 cells.
Heo Y, Park J, Lee N, Choi S, Jeon J, Han S
FASEB J. 2024; 38(15):e23859.
PMID: 39082187
PMC: 11607629.
DOI: 10.1096/fj.202400860R.